기사 (249건) 리스트형 웹진형 타일형 Seismic shift in the SMA treatment market, Zolgensma’s semi-annual sales approach KRW 1 trillion Seismic shift in the SMA treatment market, Zolgensma’s semi-annual sales approach KRW 1 trillion Novo Nordisk Ozempic, overtaking Lilly Trulicity Novo Nordisk Ozempic, overtaking Lilly Trulicity COVID-19 impact on the big pharma withered, Q2 growth reduced COVID-19 impact on the big pharma withered, Q2 growth reduced COVID-19 special advantage wanes, sales of major treatments and vaccines plunge in 2Q COVID-19 special advantage wanes, sales of major treatments and vaccines plunge in 2Q COVID-19 treatments theme stocks, foreign investors exit COVID-19 treatments theme stocks, foreign investors exit Bio-health industry exports ends soar, pharmaceuticals remain strong Bio-health industry exports ends soar, pharmaceuticals remain strong Listed drug maker’s second-quarter earnings disclosure, positive performance relay Listed drug maker’s second-quarter earnings disclosure, positive performance relay Korean top drug makers’ Q2 earnings consensus, sales – operating profit mismatch Korean top drug makers’ Q2 earnings consensus, sales – operating profit mismatch Nine Japanese pharmaceutical offshoots in Korea, the combined sales exceeded KRW 700 billion Nine Japanese pharmaceutical offshoots in Korea, the combined sales exceeded KRW 700 billion Japanese pharmaceutical companies struggle, average sales growth of 1.4% Japanese pharmaceutical companies struggle, average sales growth of 1.4% South Korea’s CPI of pharmaceutical products remains flat, while that of painkillers, cold medicines, and oriental medicine soars South Korea’s CPI of pharmaceutical products remains flat, while that of painkillers, cold medicines, and oriental medicine soars Ildong PharmaceuticalㆍIldong HoldingsㆍBukwang PharmaceuticalㆍDaewon Pharmaceutical, a surge in foreign ownership Ildong PharmaceuticalㆍIldong HoldingsㆍBukwang PharmaceuticalㆍDaewon Pharmaceutical, a surge in foreign ownership 처음처음이전이전이전11121314151617181920다음다음다음끝끝
